Direct Anterior Approach for Femoral Neck Fractures

NCT ID: NCT03695497

Last Updated: 2024-11-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

130 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-10-01

Study Completion Date

2023-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective is to examine if in patients with a dislocated femoral neck fracture who receive a total hip arthroplasty, direct anterior approach will give a better result in terms of mobilization, function and pain in the first weeks and months postoperatively, than direct lateral approach.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

first included patient 23th November 2018

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Femoral Neck Fractures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Direct anterior approach

total hip arthroplasty with direct anterior approach

Group Type EXPERIMENTAL

Direct anterior approach

Intervention Type PROCEDURE

total hip arthroplasty with DAA

Direct Lateral Approach

total hip arthroplasty with direct lateral approach

Group Type EXPERIMENTAL

Direct Lateral Approach

Intervention Type PROCEDURE

total hip arthroplasty with DLA

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Direct anterior approach

total hip arthroplasty with DAA

Intervention Type PROCEDURE

Direct Lateral Approach

total hip arthroplasty with DLA

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

DAA DLA

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Dislocated femoral neck fracture

Exclusion Criteria

* Infection around the hip (soft tissue or bone)
* Pathologic fracture
* Excessive alcohol or substance abuse that most likely will give reduced compliance
* Patients with any fractures of the long bones in the lower extremity, fracture of the spine, and/or intra-thoracic or intra-abdominal injury (i.e., multiple trauma). Because the outcomes and clinical course of patients with multiple trauma may be quite different from a non-trauma patient.
* Bedridden patients/non-walkers
* Patients with an underlying illness that doesn't have life expectancy beyond six months
* In case of severe cognitive impairment where the patients are not able to give their informed consent
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

St. Olavs Hospital

OTHER

Sponsor Role collaborator

Kristiansund Hospital

OTHER

Sponsor Role collaborator

Helse Møre og Romsdal HF

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Øystein B Lian, md phd

Role: STUDY_CHAIR

Helse Møre og Romsdal Hospital Trust (HF), Kristiansund Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kristiansund Hospital

Kristiansund, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2018/935

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.